Henan Taloph Pharmaceutical Stock Co.,Ltd (SHSE:600222) announces a share repurchase program. Under the program, the company will repurchase up to CNY 80 million worth of its A shares. The repurchase price will be not more than CNY 7 per share.

The shares repurchased will used for employee stock ownership plans or equity incentives. The repurchases will be funded by the company's own funds. The plan will be valid for 12 months.